In order to clarify any clinical associations of these 60 pathogenetic variants with the incidence of autoimmune disease, further studies will need to examine the correlation between the in vivo levels of DNase activity and the prevalence of autoimmune diseases for each genetic DNASE1 variant in larger groups of patients with autoimmune disease. Here, DNASE1 is linked to autoimmune disease.